Rephine’s expertise ensures that the approach taken is not only optimal but also strategically guided. They help navigate the many possible paths (some of which may lead to unnecessary complexity or delays) steering the validation part toward the most efficient and effective course of action. In a project of this scale, such a guidance proves to be truly invaluable.
~ Client Testimonial
About this Case Study
How Rephine enabled a successful, compliant migration of a GVP-critical pharmacovigilance system to the cloud
Faced with the challenge of migrating a highly configurable, GVP-critical pharmacovigilance system from legacy on-premise infrastructure to a cloud-based SaaS platform, a leading pharmaceutical client turned to Rephine for expert guidance. The client had no prior experience validating cloud environments and needed to safeguard regulatory compliance, data integrity, and operational continuity—without delays or disruptions.
Rephine’s consultants designed and executed a comprehensive, risk-based validation strategy tailored to the unique requirements of the system and the SaaS operating model. From data migration and configuration tracking to audit-ready documentation and end-user training, the Rephine team delivered structured support through each critical project phase.
Download the full case study to discover how Rephine helped the client:
- Validate a highly configurable system using a phased, risk-based approach.
- Verify 100% of migrated pharmacovigilance data across global safety operations.
- Integrate vendor documentation to streamline testing and reduce validation workload.
- Establish a robust audit trail and validated baseline before go-live.
- Maintain compliance and system stability through multiple SaaS upgrade cycles.
Result: A future-ready pharmacovigilance platform with verified data integrity, full compliance, and a flexible validation framework to support ongoing system changes and audits.
View other our other resources and company news
Consultoría GxP Cumplimiento práctico y preparación para inspecciones de sistemas de calidad farmacéutica en el Reino Unido
Caso práctico Apoyo a la verificación y validación de un software de dispositivo médico (MDSW)
CSV Guía práctica sobre las revisiones preliminares de la EMA a las GMP de la UE
Dispositivo médico Guía práctica de vigilancia poscomercialización (PMS) bajo el Reglamento MDR/IVDR de la UE
Actualizaciones de cumplimiento IA para los PNT farmacéuticos: Transformación de la gestión de calidad y el cumplimiento normativo
Fortalecimiento de la gestión de CAPA y excepciones
Auditoría de GMP Anexo 1 de las GMP de la UE frente a la guía de la FDA sobre procesos asépticos: cómo superar las diferencias para lograr el cumplimiento
Auditoría de GMP GMP y GDP: Garantía de calidad en el almacenamiento y el transporte de medicamentos
Blog 